Recent hypotheses suggest that GIP induces appetite suppression through independent receptors in the brain, mitigates gastrointestinal side effects of GLP-1 action, and prevents desensitization of GLP-1 receptors, thereby acting as a biased GLP-1RA [87]
measured significantly increased fractional weights of adrenals, gut, kidneys, and spleen after just 7 days of LR3 IGF-1 infusion in guinea pigs (Bastian et al., 1995)
Compound specifications The blend contains two distinct compounds at the proportions listed below
Classified as a Schedule 4 drugrequires prescription and registration with the TGA
Workplace Health & Safety, 66 (4), 191200
Anything less precise introduces measurement error larger than calculation error